Time to first dose of measles-containing vaccine and associated factors among infants in Ethiopia: a survival analysis from performance monitoring for action data
Frontiers in Public Health · 2025
DOI: 10.3389/fpubh.2025.1521602 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, 2025. Verfasst von Eyob Tilahun Abeje und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Wollo University, Dessie, Ethiopia. Hauptthemen laut MEDLINE: Measles Vaccine, Measles, Immunization Schedule, Vaccination. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The measles-containing vaccine (MCV) is a live attenuated vaccine that helps to develop lifelong immunity, and it prevents measles outbreak when administered at the right time in measles-endemic areas. Many infants received the initial dose of the measles vaccine later than the ideal time frame, and significant others missed the vaccination, causing a recurrent measles outbreak in Ethiopia. This study assessed the time to the first dose of a measles-containing vaccine and associated factors among infants in Ethiopia.
Methods
A cohort of 1,770 mother–infant pairs was analysed using data from the performance monitoring for action Ethiopia dataset. Cohort-2 Ethiopian data set was collected in Addis Ababa, Amhara, Oromia and SNNP regions between between November 2021 and August 2023. The key independent variables were socio-demographic characteristics, maternal health service utilization, and pregnancy intention. Multiple imputation was used to handle missing data. Survival analysis was conducted using R programming language version 4.4.1. Multicollinearity was assessed using Generalized variance inflation factors (GVIF), and model fit was evaluated using concordance index and overall model significance.
Results
Among 1,770 infants followed, only 27% were vaccinated timely, within 9–10 months of age (survival probability = 0.73), and 53.4% had not yet received MCV1 at 12 months of age. The hazard of receiving the first dose of measles vaccine (MCV1) was 35% lower among infants from pregnancies that were not desired at all (AHR = 0.65, 95% CI: 0.46-0.93) and 21% lower among those infants from pregnancies that were initially undesired but later became wanted (AHR = 0.79, 95% CI: 0.65–0.96), compared to infants from pregnancies that were desired from the beginning.
Conclusion
Despite progress in the uptake of the first dose of measles vaccine, timely vaccination in Ethiopia is still low, and many infants in Ethiopia miss the immunization. Institutional delivery, maternal intention regarding pregnancy, religion, and wealth quantile were key predictors of the timeliness of the first dose of measles vaccine. Interventions encouraging institutional deliveries, supporting unintended pregnancy, working with religious leaders, and conducting continuous outreach to immunization services are necessary to improve the timely uptake of the first dose of measles vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Wollo University, Dessie, Ethiopia.
- Department of Health Informatics, School of Public Health, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
- Department of Environmental Health College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
- Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
- Department of Reproductive and Family Health, School of Public Health, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
- Nossal Institute for Global Health, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.
Zitieren
APA
Abeje, E. T., Enyew, E. B., Daba, C., Asmare, L., Bayou, F. D., Arefaynie, M., Mohammed, A., Tareke, A. A., Keleb, A., Kebede, N., Tsega, Y., Endawkie, A., Kebede, S. D., & Abera, K. M. (2025). Time to first dose of measles-containing vaccine and associated factors among infants in Ethiopia: a survival analysis from performance monitoring for action data. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2025.1521602
Vancouver
Abeje ET, Enyew EB, Daba C, Asmare L, Bayou FD, Arefaynie M, et al. Time to first dose of measles-containing vaccine and associated factors among infants in Ethiopia: a survival analysis from performance monitoring for action data. Frontiers in Public Health. 2025. doi:10.3389/fpubh.2025.1521602
BibTeX
@article{Abeje2025,
author = {Abeje, Eyob Tilahun and Enyew, Ermias Bekele and Daba, Chala and Asmare, Lakew and Bayou, Fekade Demeke and Arefaynie, Mastewal and Mohammed, Anissa and Tareke, Abiyu Abadi and Keleb, Awoke and Kebede, Natnael and Tsega, Yawkal and Endawkie, Abel and Kebede, Shimels Derso and Abera, Kaleab Mesfin},
title = {Time to first dose of measles-containing vaccine and associated factors among infants in Ethiopia: a survival analysis from performance monitoring for action data},
journal = {Frontiers in Public Health},
year = {2025},
doi = {10.3389/fpubh.2025.1521602}
}
EUVIMED